Róbert Alföldi

691 total citations
15 papers, 364 citations indexed

About

Róbert Alföldi is a scholar working on Molecular Biology, Oncology and Computational Theory and Mathematics. According to data from OpenAlex, Róbert Alföldi has authored 15 papers receiving a total of 364 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Computational Theory and Mathematics. Recurrent topics in Róbert Alföldi's work include Computational Drug Discovery Methods (3 papers), Curcumin's Biomedical Applications (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Róbert Alföldi is often cited by papers focused on Computational Drug Discovery Methods (3 papers), Curcumin's Biomedical Applications (3 papers) and Retinoids in leukemia and cellular processes (3 papers). Róbert Alföldi collaborates with scholars based in Hungary, Germany and Austria. Róbert Alföldi's co-authors include László G. Puskás, Gábor J. Szebeni, László Hackler, Iván Kanizsai, L Nagy, József Á. Balog, Julio Sáez-Rodríguez, Vigneshwari Subramanian, Bence Szalai and Gábor Juhász and has published in prestigious journals such as Nucleic Acids Research, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Róbert Alföldi

15 papers receiving 359 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Róbert Alföldi Hungary 11 205 59 50 48 48 15 364
Salvador Guardiola Spain 10 256 1.2× 15 0.3× 60 1.2× 94 2.0× 99 2.1× 19 519
Michael K. Manion United States 12 397 1.9× 57 1.0× 35 0.7× 74 1.5× 47 1.0× 14 529
Livia Tepshi France 11 196 1.0× 33 0.6× 42 0.8× 104 2.2× 28 0.6× 12 324
Kristoffer Brandvold United States 9 268 1.3× 28 0.5× 56 1.1× 91 1.9× 19 0.4× 14 385
Mamta D. Naidu United States 10 195 1.0× 41 0.7× 12 0.2× 55 1.1× 53 1.1× 14 466
Abo Bakr Abdel Shakor Egypt 11 308 1.5× 43 0.7× 14 0.3× 17 0.4× 98 2.0× 23 440
Jesús Seco Spain 8 277 1.4× 18 0.3× 33 0.7× 63 1.3× 24 0.5× 10 378
Amanda Cobos‐Correa Switzerland 6 192 0.9× 33 0.6× 43 0.9× 34 0.7× 27 0.6× 9 385
Yongping Cui China 5 228 1.1× 37 0.6× 40 0.8× 99 2.1× 8 0.2× 10 437
Magdalena Otrocka Sweden 9 176 0.9× 22 0.4× 12 0.2× 36 0.8× 28 0.6× 15 284

Countries citing papers authored by Róbert Alföldi

Since Specialization
Citations

This map shows the geographic impact of Róbert Alföldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Róbert Alföldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Róbert Alföldi more than expected).

Fields of papers citing papers by Róbert Alföldi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Róbert Alföldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Róbert Alföldi. The network helps show where Róbert Alföldi may publish in the future.

Co-authorship network of co-authors of Róbert Alföldi

This figure shows the co-authorship network connecting the top 25 collaborators of Róbert Alföldi. A scholar is included among the top collaborators of Róbert Alföldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Róbert Alföldi. Róbert Alföldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Szebeni, Gábor J., Róbert Alföldi, L Nagy, et al.. (2023). Introduction of an Ultraviolet C-Irradiated 4T1 Murine Breast Cancer Whole-Cell Vaccine Model. Vaccines. 11(7). 1254–1254. 5 indexed citations
2.
Montagud, Arnau, Luis Tobalina, Pauline Traynard, et al.. (2022). Patient-specific Boolean models of signalling networks guide personalised treatments. eLife. 11. 37 indexed citations
3.
Frank, Éva, Dóra Kovács, Georg Krupitza, et al.. (2021). Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines. Biomedicine & Pharmacotherapy. 140. 111728–111728. 6 indexed citations
4.
Balog, József Á., L Nagy, Róbert Alföldi, et al.. (2020). Imidazo[1,2-b]pyrazole-7-Carboxamide Derivative Induces Differentiation-Coupled Apoptosis of Immature Myeloid Cells Such as Acute Myeloid Leukemia and Myeloid-Derived Suppressor Cells. International Journal of Molecular Sciences. 21(14). 5135–5135. 8 indexed citations
5.
Szalai, Bence, Vigneshwari Subramanian, Christian H. Holland, et al.. (2019). Signatures of cell death and proliferation in perturbation transcriptomics data—from confounding factor to effective prediction. Nucleic Acids Research. 47(19). 10010–10026. 32 indexed citations
6.
Alföldi, Róbert, József Á. Balog, Nóra Faragó, et al.. (2019). Single Cell Mass Cytometry of Non-Small Cell Lung Cancer Cells Reveals Complexity of In Vivo and Three-Dimensional Models over the Petri-Dish. Cells. 8(9). 1093–1093. 23 indexed citations
7.
Hackler, László, et al.. (2019). Enantioselective Synthesis of 8-Hydroxyquinoline Derivative, Q134 as a Hypoxic Adaptation Inducing Agent. Molecules. 24(23). 4269–4269. 9 indexed citations
8.
Balog, József Á., László Hackler, Á. Kovács, et al.. (2019). Single Cell Mass Cytometry Revealed the Immunomodulatory Effect of Cisplatin Via Downregulation of Splenic CD44+, IL-17A+ MDSCs and Promotion of Circulating IFN-γ+ Myeloid Cells in the 4T1 Metastatic Breast Cancer Model. International Journal of Molecular Sciences. 21(1). 170–170. 39 indexed citations
9.
Alföldi, Róbert, Anikó Angyal, László Hackler, et al.. (2018). Synthesis, cytotoxic characterization, and SAR study of imidazo[1,2‐b]pyrazole‐7‐carboxamides. Archiv der Pharmazie. 351(7). e1800062–e1800062. 17 indexed citations
10.
Szebeni, Gábor J., József Á. Balog, Róbert Alföldi, et al.. (2018). Imidazo[1,2-b]pyrazole-7-carboxamides Induce Apoptosis in Human Leukemia Cells at Nanomolar Concentrations. Molecules. 23(11). 2845–2845. 17 indexed citations
11.
Szebeni, Gábor J., Zsuzsanna Táncos, Liliána Z. Fehér, et al.. (2017). Real architecture For 3D Tissue (RAFT™) culture system improves viability and maintains insulin and glucagon production of mouse pancreatic islet cells. Cytotechnology. 69(2). 359–369. 14 indexed citations
12.
Szebeni, Gábor J., Ferhan Ayaydin, Iván Kanizsai, et al.. (2017). Achiral Mannich-Base Curcumin Analogs Induce Unfolded Protein Response and Mitochondrial Membrane Depolarization in PANC-1 Cells. International Journal of Molecular Sciences. 18(10). 2105–2105. 36 indexed citations
13.
Hackler, László, L Nagy, Róbert Alföldi, et al.. (2017). Mannich Curcuminoids as Potent Anticancer Agents. Archiv der Pharmazie. 350(7). 24 indexed citations
14.
Nagy, L, Gábor J. Szebeni, Péter Sipos, et al.. (2015). Curcumin and Its Analogue Induce Apoptosis in Leukemia Cells and Have Additive Effects with Bortezomib in Cellular and Xenograft Models. BioMed Research International. 2015. 1–11. 24 indexed citations
15.
Tóth, Melinda, Viktor Szegedi, Edina Varga, et al.. (2013). Overexpression of Hsp27 ameliorates symptoms of Alzheimer's disease in APP/PS1 mice. Cell Stress and Chaperones. 18(6). 759–771. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026